Back to search
Patients Undergoing Allogeneic Stem Cell Transplantation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Patients Undergoing Allogeneic Stem Cell Transplantation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Patients Undergoing Allogeneic Stem Cell Transplantation trials you may qualify forThe purpose of this phase 1 study is to determine the optimal dose of the immune suppressive drug, cyclophosphamide, following standard allogeneic stem cell tra…
This clinical trial examines sustained oral fiber supplementation for patients undergoing donor stem cell transplantation for hematological malignancies. Patien…
This is a multi-center, randomized, double-blinded, placebo controlled trial.
Reduced intensity conditioning (RIC) has emerged and been increasingly adopted as a modality to allow preparative conditioning pre transplant to be tolerated by…
This is a multi-center, non-randomized, concurrent controlled, multi-arm, Phase 1 interventional, open-label, biologic assignment-based umbrella study evaluatin…
This is a randomized phase II trial of standard-of-care reduced-intensity conditioning (RIC) with 200 versus 400 cGy of total body irradiation (TBI) in patients…
This randomized phase II trial studies the safety and how well multi-peptide cytomegalovirus (CMV)-modified vaccinia Ankara (MVA) vaccine works in reducing CMV…
The purpose of this study is to see if conditioning regimens that include personalized rabbit ATG (P-rATG) help the immune system recover sooner and decrease th…